Aptevo Therapeutics Inc. (APVO) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 52,212.79 |
| Enterprise Value | -16.94M |
| P/E Ratio | -0.01 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.53 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.18 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -1.82 |
| Return On Equity | -2.01 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -240,000 |
| EBITDA | -25.73M |
| Net Income | -25.97M |
| Diluted EPS | -87.27 |
Balance Sheet
| Total Cash | 9.8M |
| Total Cash/Share | 8.19 |
| Total Debt | 4.21M |
| Total Debt/Equity | 0.7 |
| Current Ratio | 2.08 |
| Book Value Per Share | 5.05 |
Price History
| 52-Week Change | -92.48 |
| 52-Week High | 48.78 |
| 52-Week Low | 2.58 |
| Moving Average 50 Days | 4.18 |
| Moving Average 200 Days | 8.61 |
Statistics
| Average Volume | 54,964 |
| Shares Outstanding | 1.25M |
| % Held by Institutions | 5.07 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:18 |
| Last Split Date | December 30, 2025 |
AD
